This report contains market size and forecasts of Intracranial Drug Eluting Stents in global, including the following market information:
Global Intracranial Drug Eluting Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Intracranial Drug Eluting Stents Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Intracranial Drug Eluting Stents companies in 2021 (%)
The global Intracranial Drug Eluting Stents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cobalt-chromium Alloy Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Intracranial Drug Eluting Stents include Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik and Blue Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intracranial Drug Eluting Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intracranial Drug Eluting Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Intracranial Drug Eluting Stents Market Segment Percentages, by Type, 2021 (%)
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Stainless Steel Stents
Others
Global Intracranial Drug Eluting Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Intracranial Drug Eluting Stents Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialty Clinic
Others
Global Intracranial Drug Eluting Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Intracranial Drug Eluting Stents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intracranial Drug Eluting Stents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Intracranial Drug Eluting Stents revenues share in global market, 2021 (%)
Key companies Intracranial Drug Eluting Stents sales in global market, 2017-2022 (Estimated), (Units)
Key companies Intracranial Drug Eluting Stents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Medtronic Vascular
Advantec Vascular
B.Braun Melsengen
Boston Scientific
Terumo Medical
Biosensors
Biotronik
Blue Medical
DISA Vascular
Essen
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
TEDA